EWM
AMRX icon

Empirical Wealth Management’s Amneal Pharmaceuticals AMRX Stock Holding History

Empirical Wealth Management’s Portfolio AMRX Stock Details AMRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-44,829
Closed -$449K – 901
2025
Q3 		$449K Sell
44,829
-58,643
-57% -$526K 0.01% 500
2025
Q2 		$837K Buy
103,472
+13,874
+15% +$105K 0.02% 334
2025
Q1 		$751K Buy
89,598
+43,358
+94% +$362K 0.02% 337
2024
Q4 		$366K Buy
46,240
+5,523
+14% +$46.3K 0.01% 462
2024
Q3 		$339K Buy
+40,717
New +$318K 0.01% 446

Other funds holding AMRX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
TGA
TPG GP A Fort Worth, Texas $3.68B AUM 14.99% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Empirical Wealth Management's AMRX Position: Q4 2025 in Review

Empirical Wealth Management sold out of Amneal Pharmaceuticals (AMRX) in Q4 2025, closing a stake of 44,829 shares — an estimated $449K sold.

Empirical Wealth Management first reported a position in AMRX in Q3 2024 and held it in 5 quarters. The position peaked at $837K in Q2 2025. 277 funds tracked by Wall St. Rank hold AMRX as of Q4 2025.

  • Empirical Wealth Management reported no remaining Amneal Pharmaceuticals position as of Q4 2025 after selling out during the quarter.
  • Empirical Wealth Management sold 44,829 Amneal Pharmaceuticals shares in Q4 2025, an estimated $449K.
  • Empirical Wealth Management first reported a position in Amneal Pharmaceuticals in Q3 2024 and held it in 5 quarters.
  • Empirical Wealth Management's Amneal Pharmaceuticals position peaked at $837K in Q2 2025.
  • 277 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q4 2025.

Based on Empirical Wealth Management's 13F filing for Q4 2025, filed 16 Jan 2026.